How Genetics Affects Cardiovascular Health: What Your Family History Really Means

Genetics affects cardiovascular health in ways that range from absolute (some conditions are determined almost entirely by a single gene variant) to probabilistic (most common heart disease reflects the interaction of dozens of genetic variants with lifestyle and environment). As an integrative cardiologist, Dr. Regina Druz, MD, MBA, FACC, FMCP-M integrates genetic risk assessment into cardiovascular evaluation — not to generate fatalism, but because knowing your genetic profile changes which tests you need, how aggressively to treat risk factors, and which interventions will be most effective.

How Genetics Affects Heart Disease Risk

Familial Hypercholesterolemia (FH)

Familial hypercholesterolemia is the most common serious genetic cardiovascular condition, affecting approximately 1 in 250 people — yet fewer than 10% are diagnosed. FH is caused by variants in the LDL receptor gene (LDLR), apolipoprotein B (APOB), or PCSK9 that result in severely impaired LDL clearance from the bloodstream. Untreated, FH causes LDL levels of 190–400+ mg/dL from birth, leading to premature atherosclerosis and heart attacks often in the 30s and 40s. FH should be suspected in anyone with LDL above 190 mg/dL, a family history of premature cardiovascular disease, or tendon xanthomas. Diagnosis changes management significantly — lifestyle modifications alone are insufficient and pharmacologic treatment is required.

Lipoprotein(a) — Lp(a)

Lipoprotein(a) is an LDL-like particle with an additional apolipoprotein(a) protein that makes it particularly atherogenic and thrombogenic. Lp(a) levels are 80–90% genetically determined — they are largely unresponsive to diet, exercise, or most cholesterol medications. Elevated Lp(a) (above 30 mg/dL or 75 nmol/L) is present in approximately 20% of the population and significantly increases the risk of coronary artery disease, aortic valve stenosis, and stroke — independent of all other risk factors. Standard cholesterol panels do not include Lp(a); it must be specifically ordered. Dr. Druz measures Lp(a) once in every patient — because it is genetically fixed and changes risk classification.

Hereditary Heart Disease: Cardiomyopathies

Several cardiomyopathies have strong hereditary components. Hypertrophic cardiomyopathy (HCM) — caused by variants in genes encoding sarcomere proteins — is the most common inherited cardiac condition (1 in 500) and the leading cause of sudden cardiac death in young athletes. Dilated cardiomyopathy has a genetic basis in up to 35% of cases. Arrhythmogenic right ventricular cardiomyopathy (ARVC) is caused by desmosomal gene variants and presents with ventricular arrhythmias. A family history of sudden unexplained death, heart failure before age 50, or specific cardiac conditions in a first-degree relative should trigger genetic counseling and cascade screening.

Hereditary Arrhythmia Syndromes

Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT) are inherited channelopathies — conditions affecting the ion channels that control cardiac electrical activity. They can cause sudden cardiac arrest with little or no warning, often in young people who appear otherwise healthy. These conditions are caused by variants in specific ion channel genes and are frequently identified only after a family member experiences sudden cardiac death or a resuscitated arrest.

Polygenic Risk for Common Coronary Artery Disease

Most common coronary artery disease is polygenic — determined by the cumulative effect of hundreds of common genetic variants, each contributing a small effect. Polygenic risk scores (PRS) aggregate these variants into a single score that predicts lifetime cardiovascular risk. High polygenic risk scores are associated with a 3–5x increased risk of coronary artery disease compared to the general population — comparable to the effect of familial hypercholesterolemia. Importantly, high polygenic risk can be substantially offset by lifestyle factors: people with high genetic risk who maintain healthy lifestyle have lower event rates than people with low genetic risk and poor lifestyle.

What to Do With Your Family History

A family history of early cardiovascular disease — defined as a heart attack, stroke, or sudden cardiac death in a male first-degree relative under 55 or a female first-degree relative under 65 — is a significant independent risk factor and changes clinical management. It warrants earlier and more comprehensive risk stratification, including Lp(a) measurement, coronary artery calcium scoring, and potentially genetic testing depending on the specific family history pattern.

Family history of conditions like HCM, ARVC, long QT syndrome, or unexplained sudden death in a young family member requires genetic counseling and cascade genetic testing — screening first-degree relatives who may carry the variant without yet having symptoms.

When to See a Doctor About Hereditary Heart Disease

The Integrative Cardiology Approach to Genetic Risk

At Holistic Heart Centers, Dr. Druz incorporates genetic risk assessment — including Lp(a) measurement and family history analysis — into every patient’s cardiovascular evaluation. For patients with high genetic risk, she applies more aggressive risk stratification using coronary artery calcium scoring, more frequent monitoring, and earlier consideration of pharmacologic treatment. The FIT in Your GENES® program at HHC is specifically designed around genomic cardiovascular medicine — using genetic data to personalize prevention and treatment at the individual level.

Concerned about your family history or genetic cardiovascular risk

The Step 1 Explore visit at Holistic Heart Centers includes Lp(a) measurement, family history analysis, and a personalized risk stratification plan.

References

1. Nordestgaard BG, et al. Familial Hypercholesterolaemia Is Underdiagnosed and Undertreated. Eur Heart J. 2013;34(45):3478-3490.
2. Tsimikas S. A Test in Context: Lipoprotein(a). J Am Coll Cardiol. 2017;69(6):692-711.
3. Khera AV, et al. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. N Engl J Med. 2016;375(24):2349-2358.
4. Maron BJ, et al. Hypertrophic Cardiomyopathy: Present and Future. J Am Coll Cardiol. 2012;60(8):705-715.